Cargando…
Application of median lethal concentration (LC(50)) of pathogenic microorganisms and their antigens in vaccine development
OBJECTIVE: Lack of ideal mathematical models to qualify and quantify both pathogenicity, and virulence is a dreadful setback in development of new antimicrobials and vaccines against resistance pathogenic microorganisms. Hence, the modified arithmetical formula of Reed and Muench has been integrated...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294769/ https://www.ncbi.nlm.nih.gov/pubmed/32539814 http://dx.doi.org/10.1186/s13104-020-05126-x |
_version_ | 1783546539830935552 |
---|---|
author | Saganuwan, Saganuwan Alhaji |
author_facet | Saganuwan, Saganuwan Alhaji |
author_sort | Saganuwan, Saganuwan Alhaji |
collection | PubMed |
description | OBJECTIVE: Lack of ideal mathematical models to qualify and quantify both pathogenicity, and virulence is a dreadful setback in development of new antimicrobials and vaccines against resistance pathogenic microorganisms. Hence, the modified arithmetical formula of Reed and Muench has been integrated with other formulas and used to determine bacterial colony forming unit/viral concentration, virulence and immunogenicity. RESULTS: Microorganisms’ antigens tested are Staphylococcus aureus, Streptococcus pneumoniae, Pseudomonas aeruginosa in mice and rat, Edwardsiella ictaluri, Aeromonas hydrophila, Aeromonas veronii in fish, New Castle Disease virus in chicken, Sheep Pox virus, Foot-and-Mouth Disease virus and Hepatitis A virus in vitro, respectively. The LC(50)s for the pathogens using different routes of administrations are 1.93 × 10(3)(sheep poxvirus) and 1.75 × 10(10) for Staphylococcus aureus (ATCC29213) in rat, respectively. Titer index (TI) equals N log(10) LC(50) and provides protection against lethal dose in graded fashion which translates to protection index. N is the number of vaccine dose that could neutralize the LC(50). Hence, parasite inoculum of 10(3) to 10(11) may be used as basis for determination of LC(50) and median bacterial concentrations (BC(50)).Pathogenic dose for immune stimulation should be sought at concentration about LC(10). |
format | Online Article Text |
id | pubmed-7294769 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-72947692020-06-16 Application of median lethal concentration (LC(50)) of pathogenic microorganisms and their antigens in vaccine development Saganuwan, Saganuwan Alhaji BMC Res Notes Research Note OBJECTIVE: Lack of ideal mathematical models to qualify and quantify both pathogenicity, and virulence is a dreadful setback in development of new antimicrobials and vaccines against resistance pathogenic microorganisms. Hence, the modified arithmetical formula of Reed and Muench has been integrated with other formulas and used to determine bacterial colony forming unit/viral concentration, virulence and immunogenicity. RESULTS: Microorganisms’ antigens tested are Staphylococcus aureus, Streptococcus pneumoniae, Pseudomonas aeruginosa in mice and rat, Edwardsiella ictaluri, Aeromonas hydrophila, Aeromonas veronii in fish, New Castle Disease virus in chicken, Sheep Pox virus, Foot-and-Mouth Disease virus and Hepatitis A virus in vitro, respectively. The LC(50)s for the pathogens using different routes of administrations are 1.93 × 10(3)(sheep poxvirus) and 1.75 × 10(10) for Staphylococcus aureus (ATCC29213) in rat, respectively. Titer index (TI) equals N log(10) LC(50) and provides protection against lethal dose in graded fashion which translates to protection index. N is the number of vaccine dose that could neutralize the LC(50). Hence, parasite inoculum of 10(3) to 10(11) may be used as basis for determination of LC(50) and median bacterial concentrations (BC(50)).Pathogenic dose for immune stimulation should be sought at concentration about LC(10). BioMed Central 2020-06-15 /pmc/articles/PMC7294769/ /pubmed/32539814 http://dx.doi.org/10.1186/s13104-020-05126-x Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Note Saganuwan, Saganuwan Alhaji Application of median lethal concentration (LC(50)) of pathogenic microorganisms and their antigens in vaccine development |
title | Application of median lethal concentration (LC(50)) of pathogenic microorganisms and their antigens in vaccine development |
title_full | Application of median lethal concentration (LC(50)) of pathogenic microorganisms and their antigens in vaccine development |
title_fullStr | Application of median lethal concentration (LC(50)) of pathogenic microorganisms and their antigens in vaccine development |
title_full_unstemmed | Application of median lethal concentration (LC(50)) of pathogenic microorganisms and their antigens in vaccine development |
title_short | Application of median lethal concentration (LC(50)) of pathogenic microorganisms and their antigens in vaccine development |
title_sort | application of median lethal concentration (lc(50)) of pathogenic microorganisms and their antigens in vaccine development |
topic | Research Note |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294769/ https://www.ncbi.nlm.nih.gov/pubmed/32539814 http://dx.doi.org/10.1186/s13104-020-05126-x |
work_keys_str_mv | AT saganuwansaganuwanalhaji applicationofmedianlethalconcentrationlc50ofpathogenicmicroorganismsandtheirantigensinvaccinedevelopment |